Sex Difference in Comorbid Depression in First-Episode and Drug-Naive Patients With Schizophrenia: Baseline Results From the Depression in Schizophrenia in China Study. Issue 9 (16th November 2021)

• Record Type: Journal Article
• Authors: Li, Zezhi; Liu, Xiliang; Xu, Hongjiao; Zhao, Lei; Zhou, Yongjie; Wu, Xi; Huang, Xinxin; Lang, Xiaoe; Wu, Fengchun; Zhang, Xiangyang
• Is Part Of: Psychosomatic medicine. Volume 83:Issue 9(2021)
• Page Start: 1082
• Page End: 1088
• Publication Date: 2021-11-16
• Subjects: sex difference -- schizophrenia -- major depressive episode -- comorbidity -- ANCOVA = analysis of covariance -- DSM-IV = Diagnostic and Statistical Manual of Mental Disorders -- FA = fractional anisotropy -- FEDN = first-episode drug-naive -- HAMD-17 = 17-item Hamilton Depression Rating Scale -- MDE = major depressive episode -- MS = multiplex schizophrenia -- OR = odds ratios -- PANSS = Positive and Negative Syndrome Scale -- ROC = receiver operating characteristics -- SCID-I/P = Structured Clinical Interview for DSM-IV -- SS = simplex schizophrenia; Medicine, Psychosomatic -- Periodicals; 616.0805
• DOI: 10.1097/PSY.0000000000000998
• Languages: English
• ISSNs: 0033-3174

Abstract

ABSTRACT: Objective: Comorbid depression is common in schizophrenia, and sex differences are prominent in many aspects of schizophrenia. However, few studies have investigated sex difference in comorbid depression in schizophrenia. This large sample study aimed to investigate sex differences in first-episode drug-naive (FEDN) patients with schizophrenia comorbid major depressive episode (SZ-MDE). Methods: A total of 996 FEDN patients with schizophrenia (472 males/524 females) were recruited. The 17-item Hamilton Depression Rating Scale and Positive and Negative Syndrome Scale (PANSS) were applied. Results: There was no difference in the prevalence of comorbid MDE between male and female patients with schizophrenia. Among SZ-MDE patients, men had more severe psychotic symptoms (scores of PANSS total scale, negative scale, and general psychopathology scale), more severe depressive symptoms, and higher proportion of severe depression than women (all p < .001). The early onset age of schizophrenia, smoking, and PANSS positive score were the risk factors for comorbid MDE only in female patients with schizophrenia (all p < .05). Furthermore, in female patients with SZ-MDE, smoking was associated with the severity category of depression ( p = .001, odds ratio = 2.70). Multiple variable regression demonstrated that the Hamilton Depression Rating Scale score correlated with PANSS general psychopathology ( p = .01) and total scores ( p = .04) in female SZ-MDE. Conclusions: Our results indicate sex differences in proportion of severe depression, clinical symptoms, and factors of comorbid MDE in FEDN patients with schizophrenia. These sex differences have clinical implications for the treatment of depression as related to the nature and severity of psychopathological symptoms in patients with schizophrenia.